These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 27213795)

  • 1. [Centrally acting cholinomimetics in the complex therapy of progressive glaucomatous optic neuropathy].
    Erichev VP; Mazurova YV
    Vestn Oftalmol; 2016; 132(2):33-37. PubMed ID: 27213795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Aiming for zero blindness].
    Nakazawa T
    Nippon Ganka Gakkai Zasshi; 2015 Mar; 119(3):168-93; discussion 194. PubMed ID: 25854109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The dawn of neuroprotective therapy for glaucomatous optic neuropathy].
    Yamamoto T
    Nippon Ganka Gakkai Zasshi; 2001 Dec; 105(12):866-83. PubMed ID: 11802458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Application of Retinalamin for the treatment of glaucomatous optic neuropathy].
    Makashova NV; Vasil'eva AE; Morozova NE; Ronzina IA
    Vestn Oftalmol; 2014; 130(4):71-6, 78-80. PubMed ID: 25306728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visual function-specific perimetry for indirect comparison of different ganglion cell populations in glaucoma.
    Sample PA; Bosworth CF; Blumenthal EZ; Girkin C; Weinreb RN
    Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1783-90. PubMed ID: 10845599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [New insights into the pathogenesis of glaucomatous optic neuropathy and refinement of the objective assessment of its functional damage].
    Nakamura M
    Nippon Ganka Gakkai Zasshi; 2012 Mar; 116(3):298-344; discussion 345-6. PubMed ID: 22568105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Semax in the treatment of glaucomatous optic neuropathy in patients with normalized ophthalmic tone].
    Kurysheva NI; Shpak AA; Ioĭleva EE; Galanter LI; Nagornova ND; Shubina NIu; Shlyshalova NN
    Vestn Oftalmol; 2001; 117(4):5-8. PubMed ID: 11569188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinal nerve fiber layer thickness measurements with scanning laser polarimetry predict glaucomatous visual field loss.
    Mohammadi K; Bowd C; Weinreb RN; Medeiros FA; Sample PA; Zangwill LM
    Am J Ophthalmol; 2004 Oct; 138(4):592-601. PubMed ID: 15488786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying glaucomatous vision loss with visual-function-specific perimetry in the diagnostic innovations in glaucoma study.
    Sample PA; Medeiros FA; Racette L; Pascual JP; Boden C; Zangwill LM; Bowd C; Weinreb RN
    Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3381-9. PubMed ID: 16877406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visual field changes after transient elevation of intraocular pressure in eyes with and without glaucoma.
    Chan KC; Poostchi A; Wong T; Insull EA; Sachdev N; Wells AP
    Ophthalmology; 2008 Apr; 115(4):667-72. PubMed ID: 17716733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Glaucomatous optic neuropathy].
    Nesterov AP
    Vestn Oftalmol; 1999; 115(4):3-6. PubMed ID: 10523955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting progressive glaucomatous optic neuropathy using baseline standard automated perimetry data.
    Demirel S; Fortune B; Fan J; Levine RA; Torres R; Nguyen H; Mansberger SL; Gardiner SK; Cioffi GA; Johnson CA
    Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):674-80. PubMed ID: 18936149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Frequency doubling perimetry in diagnosis of early glaucomatous optic nerve fiber damage].
    Korzekwa W; Korzekwa M; Markowska J; Wójcik-Niklewska B; Romaniuk W; Korzekwa A; Michalska-Małecka K
    Klin Oczna; 2004; 106(1-2 Suppl):222-4. PubMed ID: 15510506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baseline optical coherence tomography predicts the development of glaucomatous change in glaucoma suspects.
    Lalezary M; Medeiros FA; Weinreb RN; Bowd C; Sample PA; Tavares IM; Tafreshi A; Zangwill LM
    Am J Ophthalmol; 2006 Oct; 142(4):576-82. PubMed ID: 17011848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combining structural and functional testing for detection of glaucoma.
    Shah NN; Bowd C; Medeiros FA; Weinreb RN; Sample PA; Hoffmann EM; Zangwill LM
    Ophthalmology; 2006 Sep; 113(9):1593-602. PubMed ID: 16949444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Follow up results and pathogenetic substantiation of the effect of decompression surgery on the optic nerve in glaucomatous optic neuropathy].
    Shmyreva VF; Mostovoĭ EN; Shmeleva OA
    Vestn Oftalmol; 2001; 117(2):3-5. PubMed ID: 11510162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glaucomatous optic neuropathy and field loss in primary empty sella syndrome.
    Beattie AM; Trope GE
    Can J Ophthalmol; 1991 Dec; 26(7):377-82. PubMed ID: 1764644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation into the vasospastic mechanisms in the pathogenesis of glaucomatous neuropathy.
    Terelak-Borys B; Czechowicz-Janicka K
    Klin Oczna; 2011; 113(7-9):201-8. PubMed ID: 22256559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotection in Glaucoma: Animal Models and Clinical Trials.
    Almasieh M; Levin LA
    Annu Rev Vis Sci; 2017 Sep; 3():91-120. PubMed ID: 28731838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Determination of individually endurable intraocular pressure (pressure of target) in primary glaucoma].
    Shmyreva VF; Shmeleva-Demir OA; Mazurova IuV
    Vestn Oftalmol; 2003; 119(6):3-5. PubMed ID: 14708161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.